本文仅为文章摘要，点击阅读全文：Is the Response of Serum Lipids and Lipoproteins to Postmenopausal Hormone Replacement Therapy Modified by ApoE Genotype

Is the Response of Serum Lipids and Lipoproteins to Postmenopausal Hormone Replacement Therapy Modified by ApoE Genotype

　　Anna-Mari Heikkinen, Leo Niskanen, Markku Ryyna¨nen, Marja H. Komulainen, Marjo T. Tuppurainen, Markku Parviainen, Seppo Saarikoski

　　Abstract-Postmenopausal hormone replacement therapy (HRT) has favorable effects on the serum lipid profile, and it also decreases the risk of cardiovascular diseases. The apolipoprotein E genotype has influence on serum levels of lipids and lipoproteins; apoE allele €4 (apoE4) is associated with high total and LDL cholesterol levels. Genotype also influences the lipid responses to treatment with diet and statins, but the effect of HRT in different apoE genotypes is unknown. We studied the effects of HRT on the concentrations of serum lipids in apoE4-positive early postmenopausal women (genotypes 3/4 and 4/4) compared with apoE4-negative women (genotypes 2/3 and 3/3) in a population-based, prospective 5-year study. In all,232 early postmenopausal women were randomized into 2 treatment groups: an HRT group (n5116), which received a sequential combination of 2 mg estradiol valerate (E2Val) from day 1 to 21 and 1 mg cyproterone acetate (CPA) from day 12 to 21 (Climen), and a placebo group (n5116), which received 500 mg/d calcium lactate. Serum concentrations of total,LDL, and HDL cholesterol and triglycerides were measured at baseline and after 2 and 5 years of treatment. A total of 154 women completed the final analysis. During the follow-up period, serum total cholesterol and LDL cholesterol concentrations decreased in the HRT group in apoE4-negative women (8.1% and 17.1%, respectively; P<0.001) but did not change in the HRT group in apoE4-positive women or in the placebo group. Serum HDL cholesterol concentrations decreased in the placebo group (apoE4-negative, 3.9%, P50.015; apoE4-positive, 8.1%, P50.004) but did not change significantly in the HRT group. Serum triglyceride levels tended to increase in both study groups and genotypes (15.1% to 36.2%, P<0.038 to 0.001), but no differences were observed between the study groups or genotypes, respectively. Our finding was that in postmenopausal Finnish women LDL cholesterol levels in apoE4-negative subjects respond more favorably to HRT than those in apoE4-positive subjects. This finding has potential importance in postmenopausal women with hypercholesterolemia, if confirmed in other studies. (Arterioscler Thromb Vasc Biol. 1999;19:402-407.)

　　Key Words: ApoE genotype 、 postmenopausal hormone replacement therapy 、 LDL cholesterol 、 prospective study